ArticleCell death & disease2025

Targeting METTL3 mitigates venetoclax resistance via proteasome-mediated modulation of MCL1 in acute myeloid leukemia.

Chang-Qing Jiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.